Últimas noticias sobre HCW Biologics (NASDAQ:HCWB) Bolsa

HCW Biologics

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

HCW Biologics Inc

Red Cat Hldgs's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NYSE">RCAT</a>) short percent of float has fallen 44.64% since its last report. The company recently reported that it has 8.04 million shares sold short, which is 11.06% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.79 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Red Cat Hldgs Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743706833_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Red Cat Hldgs has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Red Cat Hldgs's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Red Cat Hldgs's peer group average for short interest as a percentage of float is 6.96%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

RCAT

Looking Into Red Cat Hldgs's Recent Short Interest

During the last three months, 23 analysts shared their evaluations of Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>), revealing diverse outlooks from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">14</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">11</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Lyft, revealing an average target of $17.24, a high estimate of $21.00, and a low estimate of $13.00. Experiencing a 10.07% decline, the current average is now lower than the previous average price target of $19.17. 
<img src="https://www.benzinga.com/files/images/story/2025/1743706831_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Lyft among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$13.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Rob Sanderson</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$20.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Brad Erickson</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$21.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Brad Erickson</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$21.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Shyam Patil</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$15.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Tom White</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$15.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$17.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Lloyd Walmsley</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$15.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Brad Erickson</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$21.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Scott Devitt</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Brian Pitz</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$15.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Doug Anmuth</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Thomas Champion</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$18.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$14.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Mark Mahaney</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$15.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Ross Sandler</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$19.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Michael McGovern</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$17.50</td>
<td>$21.00</td>
</tr>
<tr>
<td>Michael McGovern</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$21.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Lloyd Walmsley</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Michael McGovern</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$19.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$14.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Scott Devitt</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$18.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Michael Ward</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Lyft. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Lyft compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Lyft's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Lyft's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/LYFT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Lyft analyst ratings.</a>
<h2>Delving into Lyft's Background</h2>
Lyft is the second-largest ride-sharing service provider in the us and Canada, connecting riders and drivers over the Lyft app. Incorporated in 2013 and public since 2019, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft has entered the bike- and scooter-share market to bring multimodal transportation options to users.
<h3>Financial Insights: Lyft</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Lyft's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 26.6%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Lyft's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 3.98%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Lyft's ROE excels beyond industry benchmarks, reaching 8.68%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Lyft's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.15%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Lyft's debt-to-equity ratio is below the industry average at 1.53, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Basics of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

LYFT

Deep Dive Into Lyft Stock: Analyst Perspectives (23 Ratings)

Dominion Energy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>) short percent of float has fallen 17.34% since its last report. The company recently reported that it has 17.42 million shares sold short, which is 2.05% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.23 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Dominion Energy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743706828_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Dominion Energy has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Dominion Energy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Dominion Energy's peer group average for short interest as a percentage of float is 2.89%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Dominion Energy?

Looking into the current session, Blackstone Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) shares are trading at $137.25, after a 7.05% decrease. Over the past month, the stock decreased by 7.40%, but over the past year, it actually went up by 5.70%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1743706824_0.png" alt="Past Year Chart" />

<h3>Blackstone P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of 29.08 in the Capital Markets industry, Blackstone Inc. has a higher P/E ratio of 40.79. Shareholders might be inclined to think that Blackstone Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1743706824_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

News

Intraday Update

Markets

Price Over Earnings Overview: Blackstone

Celsius Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NYSE">CELH</a>) short percent of float has fallen 15.55% since its last report. The company recently reported that it has 28.39 million shares sold short, which is 15.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.3 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Celsius Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743706822_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Celsius Holdings has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Celsius Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Celsius Holdings's peer group average for short interest as a percentage of float is 5.06%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CELH

How Is The Market Feeling About Celsius Holdings?

4 analysts have expressed a variety of opinions on Axalta Coating Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXTA#NYSE">AXTA</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $43.75, along with a high estimate of $47.00 and a low estimate of $41.00. Observing a downward trend, the current average is 3.85% lower than the prior average price target of $45.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1743706820_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Axalta Coating Systems among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$42.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Michael Harrison</td>
<td>Seaport Global</td>
<td>Lowers</td>
<td>Buy</td>
<td>$47.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$45.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$41.00</td>
<td>$43.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Axalta Coating Systems. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Axalta Coating Systems compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Axalta Coating Systems's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Axalta Coating Systems's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AXTA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Axalta Coating Systems analyst ratings.</a>
<h2>All You Need to Know About Axalta Coating Systems</h2>
Axalta Coating Systems Ltd is a manufacturer, marketer and distributor of high-performance coatings systems. It operates in two segments, The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial. The Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The company operates in the geographic areas of North America, EMEA countries, Asia-Pacific, and Latin America.
<h3>Breaking Down Axalta Coating Systems's Financial Performance</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, Axalta Coating Systems showcased positive performance, achieving a revenue growth rate of 1.08% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Axalta Coating Systems's net margin excels beyond industry benchmarks, reaching 10.45%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 7.18%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Axalta Coating Systems's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.86% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Axalta Coating Systems's debt-to-equity ratio surpasses industry norms, standing at 1.8. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AXTA

Demystifying Axalta Coating Systems: Insights From 4 Analyst Reviews

WIIM

Stifel Financial shares are trading lower after Goldman Sachs cut its price target on the stock from $121 to $105.

Technical indicators alongside macro-economic factors are prompting analysts to predict <a href="https://www.benzinga.com/money/bitcoin-price-prediction">further downward momentum</a> for the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>).
What Happened: In a <a href="https://www.youtube.com/watch?app=desktop&amp;v=7GOS-SVV-Ok&amp;feature=youtu.be&amp;ab_channel=BenjaminCowen">podcast</a> on Thursday, prominen analyst Benjamin Cowen warned that the S&amp;P 500&#8217;s decline could extend into April, resembling past market downturns that have had ripple effects across both equities and crypto.
While March has historically marked a bottoming point during corrections—such as the financial crisis and pandemic crash—Cowen notes that sometimes the downturn extends into April.
One key date is mid-April, when the next inflation print is released. With new tariffs in focus, investors are watching closely for potential market reactions.
Glassnode <a href="https://x.com/glassnode/status/1907777842286391618">data</a> has flagged a death cross forming in Bitcoin's on-chain data, with BTC's 30-day volume-weighted price crossing below the 180-day. Historically, such signals have preceded 3–6 months of downside.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44630045/99-of-americans-know-bitcoin-but-only-91-know-dogecoin-why">99% Of Americans Know Bitcoin, But Only 91% Know Dogecoin: Why?</a>
Why It Matters: Cowen also pointed to a critical S&amp;P 500 metric: the S&amp;P 500 divided by the money supply, which currently sits at levels similar to past major market rejections, including 1998, the financial crisis, the pre-pandemic high and 2021/2023 resistance levels.
The 1998 rejection led to a 20–23% market drop. Cowen believes the current 10% decline could extend further to 20%, echoing that historical precedent.
He cautions against panic, reminding investors that not all 20% declines trigger recessions. In 1998, the S&amp;P 500 saw a significant rally after its correction, which could signal a similar setup in 2025.
What's Next: Cowen suggests watching for a potential market bottom in that first or second week of April, with an 11-week correction timeline possibly aligning with the next FOMC meeting in May.
He also sees a potential death cross forming on the S&amp;P 500, which historically has been followed by a short-term rally before any further declines.
If the pattern holds, both Bitcoin and equities could be in for a counter-trend bounce before the market&#8217;s next major move.
Read Next:
<ul>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/04/44628685/bitcoin-is-a-realistic-global-reserve-asset-experts-say">Bitcoin Is A Realistic Global Reserve Asset, Experts Say</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Are Bitcoin And The S&P 500 Heading For A Death Cross?

ARES

Ares Management shares are trading lower after Goldman Sachs cut its price target on the stock from $188 to $166.

<a href="https://www.theinformation.com/articles/intel-tsmc-tentatively-agree-form-chipmaking-joint-venture" title="https://www.theinformation.com/articles/intel-tsmc-tentatively-agree-form-chipmaking-joint-venture">https://www.theinformation.com/articles/intel-tsmc-tentatively-agree-form-chipmaking-joint-venture</a>

Contracts

INTC

Intel And TSMC Reaches Preliminary Agreement To Form A Joint Venture With TSMC Taking A 20% Stake In The New Company

AAPL

Apple shares are trading lower. B of A Securities cut its price target on the stock from $265 to $250.

BofA Securities analyst Michael McGovern downgraded&nbsp;&nbsp;Lyft, Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) rating to <a target="_blank" href="https://www.benzinga.com/quote/LYFT/analyst-ratings" rel="noreferrer noopener">Underperform from Buy</a> and cut the price forecast to $10.50 from $17.50 on Thursday.
The stock is trading lower on Thursday. The rerating reflects the substantial autonomous vehicle risk, especially Waymo&#8217;s rapid expansion in San Francisco and Los Angeles, and the lack of scalable autonomous vehicle partnerships that are launching in the near-term for Lyft.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42859391/uber-and-lyft-adapt-robotaxi-strategy-to-compete-in-tesla-and-waymos-market" rel="noreferrer noopener">Uber and Lyft Adapt Robotaxi Strategy to Compete in Tesla and Waymo&#8217;s Space</a>
McGovern noted Lyft&#8217;s long-term potential in the autonomous vehicle ecosystem, but given its still-nascent partnerships, the analyst lost confidence in the near-term upside.
Lyft is well positioned with 20 million users, growing 10%, plus solid ride frequency. Still, recent pricing headwinds likely impact margins, as data from Bloomberg Second Measure suggests that the average transaction value was still down in March.
McGovern initiated Lyft at Underperform in 2022 and upgraded to Buy post its 2024 Analyst Day on the expectation that Lyft could limit share loss and strengthen margins. The long-term margin outlook seemed conservative compared to Uber Technologies, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>).
Results have been mixed, with recent bookings and margin softness suggesting growth may need to reaccelerate and incremental margins improve to meet the analyst day guide.
Lyft is more exposed to Waymo versus Uber, likely generating 20%+ of bookings in California, versus Uber at less than 10%.
McGovern noted that Waymo could launch rides to San Francisco International Airport (SFO) this year or next, which would be a significant negative catalyst.
Waymo is also testing and launching other cities, but San Francisco and Los Angeles are significant for Lyft given its higher West Coast mix.
Waymo still only has 50% utilization, which could lend itself to expanded partnerships. However, with Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) launching in Texas and California, autonomous vehicle competition could grow and drive additional pricing pressure.
For fiscal 2025, McGovern reduced bookings by 2% on lower Bookings per Ride. The analyst projected $491 million for EBITDA versus $547 million prior (now below Street at $501 million in fiscal 2025 EBITDA).
Price Action: LYFT stock is down 11.10% at $11.51 at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/25/04/44634017/rxsight-analyst-flags-growth-slowdown-as-revised-outlook-misses-expectations" target="_blank" rel="noreferrer noopener">RxSight Analyst Flags Growth Slowdown As Revised Outlook Misses Expectations</a></li>
</ul>
Image via Shutterstock

Analyst Color

Downgrades

Price Target

TSLA

UBER

Lyft Stock Downgraded On Autonomous Vehicle Risk From Waymo, Tesla Competition

CORRECTION: Apple's Ticker Is "AAPL" Not "AAP"

Macro Economic Events

Econ #s

Economics

Fed's Cook Says: Sees More Evidence Of Slowing Consumer Spending, Business Investment; Sees More Emphasis On Upside Inflation Risks

RxSight, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) on Wednesday disclosed first-quarter 2025 preliminary&nbsp;<a target="_blank" href="https://www.benzinga.com/news/guidance/25/04/44624912/rxsight-warns-on-fy25-revenue-as-premium-cataract-market-faces-headwinds-stock-plunges" rel="noreferrer noopener">results and revised its FY25 outlook</a>.
The ophthalmic medical device company expects first-quarter revenue of around $37.9 million, up 28% year over year and down 6% quarter over quarter, and below the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44619582/rxsight-inc-announces-preliminary-first-quarter-2025-revenue-and-revised-2025-guidance" rel="noreferrer noopener">consensus of $40.14 million</a>.
Revised FY2025 Outlook: The company lowered the revenue outlook to $160.0 million—$175.0 million (vs. the consensus of $188.9 million) from $185.0 million—$197.0 million earlier.
On Thursday, BofA Securities analyst Craig Bijou downgraded the stock from Buy to Underperform.
&#8220;We see RXST as a relative underperformer on slowing growth and we don&#8217;t see path to 2025 upside,&#8221; he wrote.
The analyst writes lower 2025 guidance likely surprised investors.
Bijou said RxSight likely needs multiple quarters of reaccelerating top-line growth to restore investor confidence and for the stock to re-rate. BofA has lowered the <a href="https://www.benzinga.com/quote/RXST/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $36 to $22</a>.
RxSight projects the sale of 27,579 Light Adjustable Lenses (LAL/LAL+) in the first quarter, missing Street estimates by 9%. The year over year growth of 36% decelerated significantly from 60% in the fourth quarter of 2024 and 78% for fiscal year 2024.
The company installed 73 Light Delivery Devices (LDD), beating expectations by 6%. However, for the first quarter, the year-over-year growth in LAL procedures (+36%) lagged behind the growth of installed devices (+43%), suggesting that new LDD placements may not drive LAL sales as effectively as in previous years.
Price Action: RXST stock is down 38.2% at $16.15 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44631246/why-is-french-pharma-giant-sanofi-stock-trading-higher-on-thursday" target="_blank" rel="noreferrer noopener">Why Is French Pharma Giant Sanofi Stock Trading Higher On Thursday?</a></li>
</ul>
Photo: Gorodenkoff/Shutterstock.com

Health Care

General

RXST

RxSight Analyst Flags Growth Slowdown As Revised Outlook Misses Expectations

Fed's Cook Says: Is Watching For Evidence Tariffs Driving Persistent Increase In Price Pressures; Uncertainty Heightened By Economic Outlook, Government Policy Shifts; Is Watching For Evidence Of Trouble On Longer-Term Inflation Expectations; The Job Market Appears To Have Stabilized

RBC Capital Markets analyst Paul Treiber maintained BlackBerry Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) <a href="https://www.benzinga.com/quote/BB/analyst-ratings" target="_blank" rel="noreferrer noopener">with a Sector Perform</a> and lowered the price target from&nbsp;$4&nbsp;to&nbsp;$3.75 on Thursday.
The <a href="https://www.benzinga.com/news/earnings/25/04/44606004/blackberry-q4-earnings-secure-communications-and-licensing-segments-drive-impressive-performance-stock-tanks-on-dismal-guidance" target="_blank" rel="noreferrer noopener">fourth-quarter revenue</a> was $142 million (-7% Y/Y ex Cylance), above consensus at $133 million. All three revenue lines slightly beat expectations.
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42627181/blackberry-growth-hinge-on-iot-secure-communications-despite-valuation-concerns-analyst" target="_blank" rel="noreferrer noopener">BlackBerry Growth Hinges On IoT, Secure Communications Despite Valuation Concerns: Analyst</a>
Due to higher revenue, adjusted EBITDA was $21 million, above consensus at $14 million, and adjusted EPS was three cents, above consensus at two cents.
The fiscal 2026 revenue guidance for $504-534 million (-3% Y/Y mid-point ex-Cylance) was below consensus at $548 million.
The shortfall primarily reflects lower Secure Comms revenue.
BlackBerry guided fiscal 2026 adjusted EBITDA to $69-84 million, also below consensus at $89 million.
The first-quarter guidance implies fiscal 2026 is back-end loaded.
Treiber&#8217;s fiscal 2026 estimates move to $519 million revenue and $72 million adjusted EBITDA from $541 million and $73 million previously. 
Even though BlackBerry has not seen any meaningful impact from tariffs on QNX or production plans for its auto OEM customers to date, the company lowered its fiscal 2026 QNX revenue outlook from $260-270 million provided at its investor day in October to $250-270 million (10% Y/Y mid-point), with the mid-point slightly above consensus at $257 million.
The QNX backlog rose only 6% year over year (versus 27% year over year fiscal 2024), as several large expected program wins have not closed yet.
Given uncertainties, new significant wins may continue to be delayed through fiscal 2026.
The fiscal 2026 Secure Comms revenue guidance for $230-240 million (-14% Y/Y mid-point ex Cylance) was short of consensus at $274 million. Even though recurring revenue is high ($208 million ARR as of the fourth quarter), the guidance reflects the lower likelihood of large license deals with government customers amidst recent elections and changes in administration.
Due to long contracts and mission-critical software, BlackBerry has not seen churn in the U.S. Federal government and believes its U.S. business would be resilient.
Even though fiscal 2026 guidance was below consensus, BlackBerry&#8217;s profitability and positive cash flow ($35 million fiscal 2026 guidance) should eventually provide a floor for valuation.
BlackBerry is trading at 3.6 times NTM EV/S, slightly below its historical average (3.8 times); on NTM EV/EBITDA, the stock trades at 25 times, below the peer group average of 31 times.
BB Price Action:&nbsp;BlackBerry stock is down 6.66% at $3.16 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/04/44630304/qualcomm-expands-ai-ambitions-with-acquisition-of-vinais-generative-ai-division" target="_blank" rel="noreferrer noopener">Qualcomm Expands AI Ambitions With Acquisition of VinAI&#8217;s Generative AI Division</a></li>
</ul>
Photo: Shutterstock

Reiteration

Movers

Tech

BlackBerry's QNX, Secure Comms Growth Weighed Down By Tariff Uncertainties, Government Election Shifts: Analyst

Fed's Cook Says: Uncertainty Related To Tariffs Could Cause Economy to Weaken; Encouraging Inflation Has Moderated Amid Solid Growth, Healthy Job Market; Right Now, Economy Is In A 'Solid Position';  Inflation Data Already Showing Impact Of Tariffs

Fed's Cook Says: Appropriate To Maintain Current Policy For Now While Watching Data; Now Is Time for Fed To Be 'Patient But Attentive; Economy Has Entered A Period of Uncertainty; Reduced Uncertainty, Easing Inflation Would Facilitate Rate Cuts

McKesson shares are trading higher after Mizuho raised its price target on the stock from $630 to $690.

Earnings

Press Releases

HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights

HCW Biologics and WY Biotech Announce License Agreement  for Immunotherapeutic Product Candidate

Spotlight on Undervalued Nasdaq Stocks: HCWB, CRDL, NIVF, SINT, APLM – A Must-Watch This Week!

IPOs

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

HCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025

HCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial

HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements

HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results

Comments

HCW Biologics

Noticias

Últimas noticias sobre HCW Biologics (NASDAQ:HCWB) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL